In March 2026, a Foundayo is notable not only for its oral formulation but also for being among the first medications approved under the FDAs new Additionally, unlike other oral GLP-1s, it does not require the fasting and water restrictions associated with oral semaglutide, potentially making it more accessible
S-acetyl glutathione is a supplement with no documented severe side effects
The Pharmaceutical Journal
Concerted roles of LRRTM1 and SynCAM 1 in organizing prefrontal cortex synapses and cognitive functions
The medication carries a boxed warning regarding the risk of thyroid C-cell tumors based on animal studies, and it is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
Section 402 demonstration authority enables a temporary workaround to test payment/reimbursement methods without changing Part D formulary statute for obesity-only coverage